EAST TAUNTON, Mass., March 10 /PRNewswire/ -- OMNIlife science, Inc., is very pleased to announce that it has entered into an exclusive U.S. distribution agreement with Societe d'Etudes Recherches Fabrication (SERF)-Dedienne Sante of France for its NOVAE(R) Dual Mobility Acetabular Cup System. OMNI intends to begin distribution of this product in the USA as soon as U.S. FDA approval of the product is achieved.
Nik Nikolaev, Chairman of Orthopaedic Synergy, Inc., the holding company that owns OMNIlife science, Inc. and Enztec, Ltd., states, "Our distribution arrangement with SERF is in keeping with our philosophy of providing the best technology to our customers whether developed in house by our own family of companies or by partnering with very high quality manufacturers such as SERF-Dedienne Sante."
About SERF-Dedienne Sante
SERF-Dedienne Sante is a French medical implant Company with a long experience in the design, manufacturing and distribution of orthopedic and dental implants. Headquartered near Lyon-France, the Company has two manufacturing plants in Lyon and Montpellier. Since 1973, SERF-Dedienne Sante has pioneered several important developments in orthopaedic and dental technology, the most successful being the Dual Mobility Acetabular Cup Concept invented by Pr. Gilles Bousquet in the mid 1970's and which is currently generating a tremendous interest from the orthopedic community based upon excellent widely published long term clinical results. The Company is ISO 13485 & ISO 9001 certified and its products are CE marked. Thanks to its invaluable experience, flexibility, dynamic R&D and competitive manufacturing, SERF-Dedienne Sante is now expanding its strong European position to North America and Asia Pacific markets.
OMNIlife science, Inc.
